Cerebrolysin is a promising treatment for vascular dementia, but more research is needed, according to new Cochrane review


Vascular dementia is the second most common type of dementia after Alzheimer’s disease. It’s caused by damage to the network of blood vessels supplying the brain. Some symptoms are similar to those associated with Alzheimer’s and stroke, but in particular people with vascular dementia often experience difficulty thinking quickly, concentrating and communicating, as well as [read the full story…]